1900 Wealth Management LLC Invests $355,000 in Revvity, Inc. (NYSE:RVTY)

1900 Wealth Management LLC purchased a new position in Revvity, Inc. (NYSE:RVTY) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,250 shares of the company’s stock, valued at approximately $355,000.

A number of other large investors have also modified their holdings of the company. Vanguard Group Inc. acquired a new stake in shares of Revvity in the 3rd quarter worth about $1,579,487,000. Ceredex Value Advisors LLC acquired a new stake in shares of Revvity in the 4th quarter worth about $108,353,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Revvity in the 4th quarter worth about $33,568,000. Boston Trust Walden Corp acquired a new stake in shares of Revvity in the 4th quarter worth about $25,154,000. Finally, KBC Group NV acquired a new position in Revvity during the 3rd quarter valued at about $25,301,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Trading Up 1.3 %

Shares of RVTY traded up $1.27 during midday trading on Tuesday, hitting $102.04. The stock had a trading volume of 270,973 shares, compared to its average volume of 847,543. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $135.67. The business has a 50-day simple moving average of $104.69 and a two-hundred day simple moving average of $101.52. The firm has a market cap of $12.61 billion, a P/E ratio of 18.32, a price-to-earnings-growth ratio of 2.63 and a beta of 1.09. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTY) last announced its earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.15 by $0.10. Revvity had a net margin of 25.20% and a return on equity of 7.41%. The company had revenue of $695.90 million during the quarter. As a group, equities analysts forecast that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Thursday, April 18th. Revvity’s payout ratio is 5.09%.

Analysts Set New Price Targets

Several equities analysts have commented on RVTY shares. Barclays raised their target price on shares of Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, January 25th. UBS Group cut shares of Revvity from a “buy” rating to a “neutral” rating and raised their target price for the company from $105.00 to $125.00 in a research note on Tuesday, January 16th. Stifel Nicolaus raised their target price on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research note on Friday, February 2nd. Raymond James raised their target price on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Finally, Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and raised their target price for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $118.91.

Insider Buying and Selling

In related news, insider Prahlad R. Singh sold 21,217 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares in the company, valued at $9,677,288.28. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.60% of the stock is currently owned by corporate insiders.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.